Murray, Maeve P <br/><br/>
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Jul 2008 
 - 222-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1086/589250  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anti-Bacterial Agents--administration & dosage<br/>Blood Sedimentation<br/>Ciprofloxacin--administration & dosage<br/>Clarithromycin--administration & dosage<br/>Drug Resistance, Bacterial<br/>Drug Therapy, Combination<br/>Ethambutol--administration & dosage<br/>Female<br/>Humans<br/>Lung--diagnostic imaging<br/>Male<br/>Microbial Sensitivity Tests<br/>Middle Aged<br/>Mycobacterium Infections, Nontuberculous--diagnosis<br/>Mycobacterium avium--drug effects<br/>Mycobacterium avium-intracellulare Infection--diagnosis<br/>Nontuberculous Mycobacteria--drug effects<br/>Radiography<br/>Rifampin--administration & dosage<br/>Sputum--microbiology<br/>Treatment Outcome<br/>Tuberculosis, Pulmonary--diagnosis